First Time Loading...

TG Therapeutics Inc
NASDAQ:TGTX

Watchlist Manager
TG Therapeutics Inc Logo
TG Therapeutics Inc
NASDAQ:TGTX
Watchlist
Price: 16.48 USD -5.4% Market Closed
Updated: May 19, 2024
Section:
 

Relative Value

The Relative Value of one TGTX stock under the Base Case scenario is 19.19 USD. Compared to the current market price of 16.48 USD, TG Therapeutics Inc is Undervalued by 14%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TGTX Relative Value
Base Case
19.19 USD
Undervaluation 14%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

8.6
P/S
P/S
Price to Sales
8.6
vs History
63
vs Industry
51
Median 3Y
186.7
Median 5Y
116.6
Industry
8.2
Forward
9.3
More Details
60.6
P/E
P/E
Price to Earnings
60.6
vs History
4
vs Industry
3
Median 3Y
-8.7
Median 5Y
-7.9
Industry
26.1
Forward
-144
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-16.8
Median 5Y
-12.7
Industry
24.8
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-16
Median 5Y
-13.4
Industry
23.4
More Details
15.5
P/B
P/B
Price to Book Value
15.5
vs History
36
vs Industry
5
Median 3Y
13.9
Median 5Y
14.2
Industry
2.6
More Details
8.2
EV/S
EV/S
Enterprise Value to Sales
8.2
vs History
63
vs Industry
41
Median 3Y
165.5
Median 5Y
98.2
Industry
7.4
Forward
8.8
More Details
8.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
8.8
vs History
53
vs Industry
42
Median 3Y
184.4
Median 5Y
11.3
Industry
9.1
More Details
49
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
49
vs History
4
vs Industry
2
Median 3Y
-8.5
Median 5Y
-7.5
Industry
4.6
Forward
-428.1
More Details
49.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
49.2
vs History
4
vs Industry
2
Median 3Y
-8.5
Median 5Y
-7.5
Industry
4.4
Forward
-364.2
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-15.1
Median 5Y
-12.2
Industry
6.4
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-15
Median 5Y
-12.2
Industry
3.8
More Details
32.3
EV/IC
EV/IC
Enterprise Value to IC
32.3
vs History
31
vs Industry
9
Median 3Y
35.4
Median 5Y
-41.1
Industry
4.9
More Details

Multiples Across Competitors

TGTX Competitors Multiples
TG Therapeutics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
TG Therapeutics Inc
NASDAQ:TGTX
2.5B USD 8.6 60.6 49 49.2
US
Abbvie Inc
NYSE:ABBV
293.9B USD 5.4 49.4 13.8 21.3
US
Amgen Inc
NASDAQ:AMGN
167.6B USD 5.7 44.5 18.7 30.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115B USD 11.3 28.6 24 25.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
108.2B USD 8.3 28.1 22.7 25.2
AU
CSL Ltd
ASX:CSL
135.3B AUD 6.4 36.6 22.1 27.4
US
Gilead Sciences Inc
NASDAQ:GILD
84.4B USD 3.1 174.3 8.8 11.6
US
Moderna Inc
NASDAQ:MRNA
50.9B USD 9.9 -8.5 -9.4 -8.4
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
33.6B USD 3.5 28.8 14.6 18.3
KR
Celltrion Inc
KRX:068270
39.7T KRW 18.2 74.1 45.3 62.4

See Also

Summary
TGTX intrinsic value, competitors valuation, and company profile.
DCF Valuation
TGTX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TGTX stock valuation using valuation multiples.
Wall Street Estimates
TGTX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TGTX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.